Drugs / MultiGeneAngio
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00956332 | Feb 2010 → Aug 2011 | limb ischemia, peripheral arterial disease | MultiGene Vascular Systems Ltd. | Unknown | No outcome recorded |
| Phase 1/2 | NCT00390767 | Oct 2006 → Dec 2010 | intermittent vascular claudication, peripheral arterial disease | MultiGene Vascular Systems Ltd. | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MultiGeneAngio | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00956332 ↗ |
| Modality | Cell therapy | “MultiGeneAngio, a cell therapy product produced from the patient's own cells” NCT00390767 ↗ |
| Route | Other | “a single intra-arterial infusion of a suspension” PMID 26584888 ↗ Nov 2015 |